摘要:
The invention concerns a compound of formula (I) for preparing pharmaceutical compositions designed to increase the proportions of circulating, cellular and extracellular TGF-β1.
摘要:
The invention concerns the use of agonists of adrenergic beta-3 receptors for preparing wound-healing medicines and pharmaceutical compositions for said use.
摘要:
The invention concerns the use of direct or indirect selective inhibitors of the Xa factor acting via antithrombin III, on their own or combined with one or several compounds with platelet antiaggregating activity, for preparing medicines for preventing or treating arterial thromboembolism. The invention also concerns pharmaceutical compositions containing one or several direct or indirect selective inhibitors of Xa factor acting via antithrombin III in association with one or several compounds with platelet antiaggregating activity, and, optionally one or several pharmaceutically acceptable carriers.
摘要:
The invention relates to synthetic polysaccharides in an acid form and their pharmaceutically acceptable salts, the anionic form of which complies with one of the formulas (I) to (V) described in claim 1. Said polysaccharides can be used in the treatment of diseases linked to coagulation disorders.